Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial β-cell protection in individuals with type 2 diabetes

AIM: Postprandial release of intact proinsulin (IP) is an independent marker for β-cell dysfunction in patients with type 2 diabetes. This open-label, parallel-group, two-arm, pilot study compared the β-cell protective effect of adding insulin glargine (GLA) vs. NPH insulin to ongoing metformin. MAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Forst, T, Larbig, M, Hohberg, C, Forst, S, Diessel, S, Borchert, M, Roth, W, Pfützner, A
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871167/
https://www.ncbi.nlm.nih.gov/pubmed/20415692
http://dx.doi.org/10.1111/j.1463-1326.2010.01209.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871167/
https://www.ncbi.nlm.nih.gov/pubmed/20415692
http://dx.doi.org/10.1111/j.1463-1326.2010.01209.x

Ejemplares similares